(ZBRA) Zebra Technologies - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US9892071054
Stock: Printers, Scanners, Mobile Computers, Software, Tags
Total Rating 36
Risk 89
Buy Signal -1.57
| Risk 5d forecast | |
|---|---|
| Volatility | 45.9% |
| Relative Tail Risk | -7.68% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.42 |
| Alpha | -59.16 |
| Character TTM | |
|---|---|
| Beta | 1.696 |
| Beta Downside | 1.616 |
| Drawdowns 3y | |
|---|---|
| Max DD | 49.55% |
| CAGR/Max DD | -0.19 |
EPS (Earnings per Share)
Revenue
Description: ZBRA Zebra Technologies March 03, 2026
Zebra Technologies Corporation (NASDAQ: ZBRA) specializes in enterprise-grade automatic identification and data capture (AIDC) solutions. Headquartered in Illinois, the company operates via two segments: Connected Frontline and Asset Visibility and Automation. Its product portfolio includes thermal barcode printers, RFID encoders, rugged mobile computers, and industrial machine vision cameras. These hardware assets are complemented by cloud-based software for workforce management and prescriptive analytics.
As a key enabler of the Industrial Internet of Things (IIoT), Zebra provides the digital infrastructure necessary for real-time asset tracking and workflow optimization across complex supply chains. The company targets sectors such as retail, e-commerce, logistics, and healthcare, utilizing a distribution strategy that combines direct sales with an extensive network of channel partners. Investors evaluating Zebras operational efficiency and sector performance can explore further data on ValueRay.
Headlines to watch out for
- Enterprise mobile computing demand drives revenue
- Supply chain disruptions impact manufacturing costs
- Healthcare technology adoption boosts segment growth
- Retail and e-commerce investment influences sales
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 419.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA -2.20 > 1.0 |
| NWC/Revenue: -1.04% < 20% (prev 14.78%; Δ -15.81% < -1%) |
| CFO/TA 0.11 > 3% & CFO 917.0m > Net Income 419.0m |
| Net Debt (2.69b) to EBITDA (1.04b): 2.60 < 3 |
| Current Ratio: 0.97 > 1.5 & < 3 |
| Outstanding Shares: last quarter (50.7m) vs 12m ago -2.44% < -2% |
| Gross Margin: 47.31% > 18% (prev 0.48%; Δ 4.68k% > 0.5%) |
| Asset Turnover: 65.53% > 50% (prev 62.51%; Δ 3.01% > 0%) |
| Interest Coverage Ratio: 4.17 > 6 (EBITDA TTM 1.04b / Interest Expense TTM 204.0m) |
Altman Z'' 3.80
| A: -0.01 (Total Current Assets 1.80b - Total Current Liabilities 1.85b) / Total Assets 8.50b |
| B: 0.62 (Retained Earnings 5.28b / Total Assets 8.50b) |
| C: 0.10 (EBIT TTM 851.0m / Avg Total Assets 8.23b) |
| D: 1.07 (Book Value of Equity 5.26b / Total Liabilities 4.91b) |
| Altman-Z'' Score: 3.80 = AA |
Beneish M -2.85
| DSRI: 1.08 (Receivables 832.0m/712.0m, Revenue 5.40b/4.98b) |
| GMI: 1.02 (GM 47.31% / 48.44%) |
| AQI: 1.15 (AQ_t 0.73 / AQ_t-1 0.63) |
| SGI: 1.08 (Revenue 5.40b / 4.98b) |
| TATA: -0.06 (NI 419.0m - CFO 917.0m) / TA 8.50b) |
| Beneish M-Score: -2.85 (Cap -4..+1) = A |
What is the price of ZBRA shares?
As of March 13, 2026, the stock is trading at USD 213.67 with a total of 572,669 shares traded.
Over the past week, the price has changed by -11.16%, over one month by -25.57%, over three months by -23.97% and over the past year by -26.91%.
Over the past week, the price has changed by -11.16%, over one month by -25.57%, over three months by -23.97% and over the past year by -26.91%.
Is ZBRA a buy, sell or hold?
Zebra Technologies has received a consensus analysts rating of 4.05.
Therefore, it is recommended to buy ZBRA.
- StrongBuy: 9
- Buy: 2
- Hold: 8
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ZBRA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 336.4 | 57.4% |
| Analysts Target Price | 336.4 | 57.4% |
ZBRA Fundamental Data Overview March 10, 2026
P/E Trailing = 26.8849
P/E Forward = 11.976
P/S = 2.0622
P/B = 3.0114
P/EG = 0.4607
Revenue TTM = 5.40b USD
EBIT TTM = 851.0m USD
EBITDA TTM = 1.04b USD
Long Term Debt = 2.36b USD (from longTermDebt, last quarter)
Short Term Debt = 141.0m USD (from shortTermDebt, last quarter)
Debt = 2.82b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.69b USD (from netDebt column, last quarter)
Enterprise Value = 13.82b USD (11.13b + Debt 2.82b - CCE 125.0m)
Interest Coverage Ratio = 4.17 (Ebit TTM 851.0m / Interest Expense TTM 204.0m)
EV/FCF = 16.63x (Enterprise Value 13.82b / FCF TTM 831.0m)
FCF Yield = 6.01% (FCF TTM 831.0m / Enterprise Value 13.82b)
FCF Margin = 15.40% (FCF TTM 831.0m / Revenue TTM 5.40b)
Net Margin = 7.77% (Net Income TTM 419.0m / Revenue TTM 5.40b)
Gross Margin = 47.31% ((Revenue TTM 5.40b - Cost of Revenue TTM 2.84b) / Revenue TTM)
Gross Margin QoQ = 44.61% (prev 48.03%)
Tobins Q-Ratio = 1.63 (Enterprise Value 13.82b / Total Assets 8.50b)
Interest Expense / Debt = 1.31% (Interest Expense 37.0m / Debt 2.82b)
Taxrate = 28.57% (28.0m / 98.0m)
NOPAT = 607.9m (EBIT 851.0m * (1 - 28.57%))
Current Ratio = 0.97 (Total Current Assets 1.80b / Total Current Liabilities 1.85b)
Debt / Equity = 0.78 (Debt 2.82b / totalStockholderEquity, last quarter 3.59b)
Debt / EBITDA = 2.60 (Net Debt 2.69b / EBITDA 1.04b)
Debt / FCF = 3.24 (Net Debt 2.69b / FCF TTM 831.0m)
Total Stockholder Equity = 3.64b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.09% (Net Income 419.0m / Total Assets 8.50b)
RoE = 11.50% (Net Income TTM 419.0m / Total Stockholder Equity 3.64b)
RoCE = 14.17% (EBIT 851.0m / Capital Employed (Equity 3.64b + L.T.Debt 2.36b))
RoIC = 10.30% (NOPAT 607.9m / Invested Capital 5.90b)
WACC = 9.89% (E(11.13b)/V(13.94b) * Re(12.16%) + D(2.82b)/V(13.94b) * Rd(1.31%) * (1-Tc(0.29)))
Discount Rate = 12.16% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.01%
[DCF] Terminal Value 63.40% ; FCFF base≈880.2m ; Y1≈605.6m ; Y5≈303.6m
[DCF] Fair Price = 34.65 (EV 4.40b - Net Debt 2.69b = Equity 1.70b / Shares 49.2m; r=9.89% [WACC]; 5y FCF grow -36.52% → 2.90% )
EPS Correlation: 1.22 | EPS CAGR: 2.07% | SUE: 0.0 | # QB: 0
Revenue Correlation: -11.62 | Revenue CAGR: 0.79% | SUE: 0.69 | # QB: 0
EPS next Quarter (2026-06-30): EPS=4.21 | Chg7d=+0.000 | Chg30d=-0.013 | Revisions Net=+2 | Analysts=15
EPS current Year (2026-12-31): EPS=18.06 | Chg7d=+0.009 | Chg30d=+0.396 | Revisions Net=+11 | Growth EPS=+14.0% | Growth Revenue=+11.2%
EPS next Year (2027-12-31): EPS=20.19 | Chg7d=+0.111 | Chg30d=+0.397 | Revisions Net=+9 | Growth EPS=+11.8% | Growth Revenue=+5.5%
[Analyst] Revisions Ratio: +0.17 (7 Up / 5 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.4% (Discount Rate 12.2% - Earnings Yield 3.7%)
[Growth] Growth Spread = +5.5% (Analyst 13.9% - Implied 8.4%)
P/E Forward = 11.976
P/S = 2.0622
P/B = 3.0114
P/EG = 0.4607
Revenue TTM = 5.40b USD
EBIT TTM = 851.0m USD
EBITDA TTM = 1.04b USD
Long Term Debt = 2.36b USD (from longTermDebt, last quarter)
Short Term Debt = 141.0m USD (from shortTermDebt, last quarter)
Debt = 2.82b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.69b USD (from netDebt column, last quarter)
Enterprise Value = 13.82b USD (11.13b + Debt 2.82b - CCE 125.0m)
Interest Coverage Ratio = 4.17 (Ebit TTM 851.0m / Interest Expense TTM 204.0m)
EV/FCF = 16.63x (Enterprise Value 13.82b / FCF TTM 831.0m)
FCF Yield = 6.01% (FCF TTM 831.0m / Enterprise Value 13.82b)
FCF Margin = 15.40% (FCF TTM 831.0m / Revenue TTM 5.40b)
Net Margin = 7.77% (Net Income TTM 419.0m / Revenue TTM 5.40b)
Gross Margin = 47.31% ((Revenue TTM 5.40b - Cost of Revenue TTM 2.84b) / Revenue TTM)
Gross Margin QoQ = 44.61% (prev 48.03%)
Tobins Q-Ratio = 1.63 (Enterprise Value 13.82b / Total Assets 8.50b)
Interest Expense / Debt = 1.31% (Interest Expense 37.0m / Debt 2.82b)
Taxrate = 28.57% (28.0m / 98.0m)
NOPAT = 607.9m (EBIT 851.0m * (1 - 28.57%))
Current Ratio = 0.97 (Total Current Assets 1.80b / Total Current Liabilities 1.85b)
Debt / Equity = 0.78 (Debt 2.82b / totalStockholderEquity, last quarter 3.59b)
Debt / EBITDA = 2.60 (Net Debt 2.69b / EBITDA 1.04b)
Debt / FCF = 3.24 (Net Debt 2.69b / FCF TTM 831.0m)
Total Stockholder Equity = 3.64b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.09% (Net Income 419.0m / Total Assets 8.50b)
RoE = 11.50% (Net Income TTM 419.0m / Total Stockholder Equity 3.64b)
RoCE = 14.17% (EBIT 851.0m / Capital Employed (Equity 3.64b + L.T.Debt 2.36b))
RoIC = 10.30% (NOPAT 607.9m / Invested Capital 5.90b)
WACC = 9.89% (E(11.13b)/V(13.94b) * Re(12.16%) + D(2.82b)/V(13.94b) * Rd(1.31%) * (1-Tc(0.29)))
Discount Rate = 12.16% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.01%
[DCF] Terminal Value 63.40% ; FCFF base≈880.2m ; Y1≈605.6m ; Y5≈303.6m
[DCF] Fair Price = 34.65 (EV 4.40b - Net Debt 2.69b = Equity 1.70b / Shares 49.2m; r=9.89% [WACC]; 5y FCF grow -36.52% → 2.90% )
EPS Correlation: 1.22 | EPS CAGR: 2.07% | SUE: 0.0 | # QB: 0
Revenue Correlation: -11.62 | Revenue CAGR: 0.79% | SUE: 0.69 | # QB: 0
EPS next Quarter (2026-06-30): EPS=4.21 | Chg7d=+0.000 | Chg30d=-0.013 | Revisions Net=+2 | Analysts=15
EPS current Year (2026-12-31): EPS=18.06 | Chg7d=+0.009 | Chg30d=+0.396 | Revisions Net=+11 | Growth EPS=+14.0% | Growth Revenue=+11.2%
EPS next Year (2027-12-31): EPS=20.19 | Chg7d=+0.111 | Chg30d=+0.397 | Revisions Net=+9 | Growth EPS=+11.8% | Growth Revenue=+5.5%
[Analyst] Revisions Ratio: +0.17 (7 Up / 5 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.4% (Discount Rate 12.2% - Earnings Yield 3.7%)
[Growth] Growth Spread = +5.5% (Analyst 13.9% - Implied 8.4%)